Yoko Ono

1.9k total citations
62 papers, 1.4k citations indexed

About

Yoko Ono is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Yoko Ono has authored 62 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 15 papers in Immunology and 9 papers in Genetics. Recurrent topics in Yoko Ono's work include Acute Myeloid Leukemia Research (6 papers), Immune Cell Function and Interaction (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Yoko Ono is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Immune Cell Function and Interaction (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Yoko Ono collaborates with scholars based in Japan, United States and Germany. Yoko Ono's co-authors include Emanual Maverakis, Heidi Goodarzi, Hideaki Hara, Kazuhiro Tsuruma, Masamitsu Shimazawa, Yoshinori Miyamura, Miki Shirakawa Garcia, Masafumi Takata, Hirotaka Tanaka and Yasuhiro Noda and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Yoko Ono

61 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoko Ono Japan 22 481 327 193 188 163 62 1.4k
Hamid Rezvani France 27 1.1k 2.3× 252 0.8× 281 1.5× 273 1.5× 181 1.1× 106 2.2k
Chiara Foglieni Italy 26 905 1.9× 247 0.8× 273 1.4× 187 1.0× 235 1.4× 61 2.0k
Christian Ploner Austria 27 1.3k 2.7× 407 1.2× 185 1.0× 473 2.5× 140 0.9× 59 2.5k
Alessia Parodi Italy 21 424 0.9× 365 1.1× 167 0.9× 201 1.1× 81 0.5× 43 1.2k
Keisuke Okabe Japan 19 618 1.3× 104 0.3× 200 1.0× 302 1.6× 234 1.4× 73 1.7k
Wai M. Liu United Kingdom 20 370 0.8× 305 0.9× 65 0.3× 377 2.0× 120 0.7× 55 1.4k
Frederique M. Poulet United States 10 634 1.3× 987 3.0× 241 1.2× 285 1.5× 397 2.4× 12 2.3k
Laura Brandolini Italy 22 326 0.7× 327 1.0× 88 0.5× 329 1.8× 229 1.4× 57 1.2k
Subhanjan Mondal United States 19 706 1.5× 416 1.3× 77 0.4× 112 0.6× 150 0.9× 30 1.4k
Yuko Ito Japan 28 1.4k 2.8× 281 0.9× 426 2.2× 226 1.2× 94 0.6× 103 2.3k

Countries citing papers authored by Yoko Ono

Since Specialization
Citations

This map shows the geographic impact of Yoko Ono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko Ono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko Ono more than expected).

Fields of papers citing papers by Yoko Ono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoko Ono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko Ono. The network helps show where Yoko Ono may publish in the future.

Co-authorship network of co-authors of Yoko Ono

This figure shows the co-authorship network connecting the top 25 collaborators of Yoko Ono. A scholar is included among the top collaborators of Yoko Ono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoko Ono. Yoko Ono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watanabe, Miwa, et al.. (2023). Screening for DAX1/EWS‐FLI1 functional inhibitors identified dihydroorotate dehydrogenase as a therapeutic target for Ewing's sarcoma. Cancer Medicine. 12(8). 9802–9814. 4 indexed citations
2.
Ono, Yoko & Hidemasa Bono. (2022). Exploratory meta-analysis of hypoxic transcriptomes using a precise transcript reference sequence set. Life Science Alliance. 6(1). e202201518–e202201518. 1 indexed citations
3.
Yoshioka, Kentaro, Yosuke Hirakawa, Makoto Kurano, et al.. (2021). Lysophosphatidylcholine mediates fast decline in kidney function in diabetic kidney disease. Kidney International. 101(3). 510–526. 68 indexed citations
4.
Ohuchi, Kazuki, Yoko Ono, Kazuhiro Tsuruma, et al.. (2018). A Docosahexaenoic Acid-Derived Pro-resolving Agent, Maresin 1, Protects Motor Neuron Cells Death. Neurochemical Research. 43(7). 1413–1423. 18 indexed citations
5.
Sawada, S, Yoko Ono, Yusuke Egashira, et al.. (2017). In Models of Intracerebral Hemorrhage, Rivaroxaban is Superior to Warfarin to Limit Blood Brain Barrier Disruption and Hematoma Expansion. Current Neurovascular Research. 14(2). 96–103. 7 indexed citations
6.
Ono, Yoko, Kazuhiro Tsuruma, Masafumi Takata, Masamitsu Shimazawa, & Hideaki Hara. (2016). Glycoprotein nonmetastatic melanoma protein B extracellular fragment shows neuroprotective effects and activates the PI3K/Akt and MEK/ERK pathways via the Na+/K+-ATPase. Scientific Reports. 6(1). 23241–23241. 48 indexed citations
7.
Ono, Yoko, Hirohito Yano, Noriyuki Nakayama, et al.. (2016). Glycoprotein nonmetastatic melanoma protein B (GPNMB) promotes the progression of brain glioblastoma via Na+/K+-ATPase. Biochemical and Biophysical Research Communications. 481(1-2). 7–12. 19 indexed citations
8.
Ohuchi, Kazuki, Michinori Funato, Zenichiro Kato, et al.. (2015). Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog. Stem Cells Translational Medicine. 5(2). 152–163. 26 indexed citations
9.
Nakano, Yusuke, Yukiya Suzuki, Toshinori Takagi, et al.. (2014). Glycoprotein nonmetastatic melanoma protein B (GPNMB) as a novel neuroprotective factor in cerebral ischemia–reperfusion injury. Neuroscience. 277. 123–131. 54 indexed citations
10.
Ono, Yoko, Hirotaka Tanaka, Kazuhiro Tsuruma, Masamitsu Shimazawa, & Hideaki Hara. (2013). A sigma-1 receptor antagonist (NE-100) prevents tunicamycin-induced cell death via GRP78 induction in hippocampal cells. Biochemical and Biophysical Research Communications. 434(4). 904–909. 21 indexed citations
11.
Alatrash, Gheath, Yoko Ono, Анна Сергеева, et al.. (2012). The Role of Antigen Cross-presentation From Leukemia Blasts on Immunity to the Leukemia-associated Antigen PR1. Journal of Immunotherapy. 35(4). 309–320. 19 indexed citations
12.
Maverakis, Emanual, et al.. (2011). The Etiology of Paraneoplastic Autoimmunity. Clinical Reviews in Allergy & Immunology. 42(2). 135–144. 68 indexed citations
13.
Garcia, Miki Shirakawa, Yoko Ono, Steve R. Martinez, et al.. (2011). Complete regression of subcutaneous and cutaneous metastatic melanoma with high-dose intralesional interleukin 2 in combination with topical imiquimod and retinoid cream. Melanoma Research. 21(3). 235–243. 25 indexed citations
14.
Maverakis, Emanual, et al.. (2009). Light, including ultraviolet. Journal of Autoimmunity. 34(3). J247–J257. 191 indexed citations
15.
Oka, Satoko, Kazuya Sato, Masuzu Ueda, et al.. (2007). Flow cytometric evaluation of endoscopic biopsy specimens from patients with gastrointestinal tract B-cell lymphoma: a preliminary report. 30. 173–180. 2 indexed citations
16.
Imamura, Yorishige, et al.. (2003). A novel methylthio metabolite of s-triazolo[3,4-a]phthalazine, a lead compound for the development of antianxiety drugs, in rats. Life Sciences. 74(1). 29–36. 16 indexed citations
17.
Ono, Yoko, et al.. (2003). Transfusion-related problems following major ABO-incompatible bone marrow transplantation. Transfusion and Apheresis Science. 28(2). 155–161. 1 indexed citations
18.
Itoh, Shigeki, Takeshi Sugawara, Yoko Ono, et al.. (2001). Clonal evolution of blasts in an elderly patient with CD56+ relapsed acute promyelocytic leukemia. American Journal of Hematology. 69(1). 59–63. 4 indexed citations
19.
Ono, Yoko, et al.. (1996). Determination of isonicotinic acid in the presence of isoniazid and acetylisoniazid Studies on isonicotinic acid formation from isoniazid in isolated rat hepatocytes. Journal of Chromatography B Biomedical Sciences and Applications. 677(2). 339–343. 3 indexed citations
20.
Yamada, E., et al.. (1989). Production of Antibodies Directed against Microtubular Aggregates in Hepatocytes of Chimpanzees with Non-A, Non-B Hepatitis. Journal of General Virology. 70(6). 1401–1407. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hamid Rezvani Breakdown of academic impact, for papers by Chiara Foglieni Breakdown of academic impact, for papers by Christian Ploner Breakdown of academic impact, for papers by Alessia Parodi Breakdown of academic impact, for papers by Keisuke Okabe Breakdown of academic impact, for papers by Wai M. Liu Breakdown of academic impact, for papers by Frederique M. Poulet Breakdown of academic impact, for papers by Laura Brandolini Breakdown of academic impact, for papers by Subhanjan Mondal Breakdown of academic impact, for papers by Yuko Ito
Rankless by CCL
2026